• Mashup Score: 18

    Colonoscopy is widely considered the gold standard for large bowel investigations, allowing diagnosis and treatment to be undertaken; results from randomised trials of its use in colorectal cancer screening have been eagerly awaited. The findings from the first such trial—NordICC—were presented at UEG Week 2022 and published in the New England Journal of Medicine. In the trial, individuals aged…

    Tweet Tweets with this article
    • RT @LancetGastroHep: New Editorial on #NordICC - Controversy over colonoscopy for colorectal cancer screening https://t.co/Ms5niCIiZd #cr…

  • Mashup Score: 11

    Colonoscopy is widely considered the gold standard for large bowel investigations, allowing diagnosis and treatment to be undertaken; results from randomised trials of its use in colorectal cancer screening have been eagerly awaited. The findings from the first such trial—NordICC—were presented at UEG Week 2022 and published in the New England Journal of Medicine. In the trial, individuals aged…

    Tweet Tweets with this article
    • RT @LancetGastroHep: New Editorial on #NordICC - Controversy over colonoscopy for colorectal cancer screening https://t.co/Ms5niCIiZd #cr…

  • Mashup Score: 1

    Colonoscopy is widely considered the gold standard for large bowel investigations, allowing diagnosis and treatment to be undertaken; results from randomised trials of its use in colorectal cancer screening have been eagerly awaited. The findings from the first such trial—NordICC—were presented at UEG Week 2022 and published in the New England Journal of Medicine. In the trial, individuals aged…

    Tweet Tweets with this article
    • New Editorial on #NordICC - Controversy over colonoscopy for colorectal cancer screening https://t.co/Ms5niCIiZd #crcsm #colorectalcancer #screening #colonoscopy #GITwitter

  • Mashup Score: 1

    Despite some sensational headlines following the publication of NordICC trial data in The New England Journal of Medicine, it’s important to understand that this study does not change the value of colonoscopy.

    Tweet Tweets with this article
    • Despite some sensational headlines following the publication of #NordICC trial data in @NEJM, it’s important to understand that this study does not change the value of #colonoscopy. @DHPAnews #GITwitter #MedTwitter https://t.co/ldVLcDYhLD

  • Mashup Score: 0

    Following publication of NordICC trial data in The New England Journal of Medicine, which found a modest benefit for colonoscopy screening in colorectal cancer, the AGA fired back, noting that colonoscopy is only effective “if it is completed.” The controversial data, also presented at UEG Week in Vienna, reported that colonoscopies reduced the risk for colon cancer by approximately

    Tweet Tweets with this article
    • #ICYMI: @AmerGastroAssn speaks out on #controversial #NordICC data published in @NEJM citing modest #colonoscopy benefit for #CRC @HemOncToday #GITwitter #MedTwitter #oncology https://t.co/hFfc0OLg7l